XML 71 R56.htm IDEA: XBRL DOCUMENT v3.24.2
Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details) - EUR (€)
€ / shares in Units, € in Millions
6 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Disclosure of transactions between related parties [line items]    
Investments accounted for using the equity method € 315 € 424
Subordinated liabilities € 200  
EUROAPI    
Disclosure of transactions between related parties [line items]    
Proportion of ownership interest in associate [1] 29.80%  
Investments in associates [1] € 72 € 162
EUROAPI    
Disclosure of transactions between related parties [line items]    
Stock price (in euro per share) € 2.55 € 5.73
MSP Vaccine Company | MCM Vaccine BV    
Disclosure of transactions between related parties [line items]    
Proportion of ownership interest in subsidiary 100.00%  
Infraserv GmbH & Co. Höchst KG    
Disclosure of transactions between related parties [line items]    
Proportion of ownership interest in joint venture [2] 31.20%  
Investments in joint ventures [2] € 89 € 90
MSP Vaccine Company    
Disclosure of transactions between related parties [line items]    
Proportion of ownership interest in joint venture [3] 50.00%  
Investments in joint ventures [3] € 90 96
Other investments    
Disclosure of transactions between related parties [line items]    
Proportion of ownership interest in joint venture 0.00%  
Investments in joint ventures € 64 € 76
[1]
(a)The investment in EUROAPI includes an impairment loss determined by reference to the quoted market price (€2.55 as of June 30, 2024, and €5.73 as of December 31, 2023).
[2] Joint venture.
[3] Joint venture MSP Vaccine Company owns 100% of MCM Vaccine BV